Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)

Thierry Jahan, Lin Gu, Robert Kratzke, Arkadiusz Dudek, Gregory A. Otterson, Xiaofei Wang, Mark Green, Everett E. Vokes, Hedy Lee Kindler

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)'. Together they form a unique fingerprint.

Medicine & Life Sciences